文献速递免疫规划卫生政策与健康促进

含麻疹成分疫苗接种活动中引入接种卡核查的成本节约机会

The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns.
PubMed 文献 · Vaccine · 2019-08-27

在常规免疫薄弱的国家,补充免疫活动通常为所有儿童接种疫苗,已接种2剂及以上者可能接受不必要剂量而增加成本。研究采用蒙特卡洛模拟评估选择性接种(核查接种记录后决定是否接种)在何种条件下可净节约成本,发现当儿童同时具有2剂以上既往接种史且有可用记录的高联合概率时可能节约成本,且净节约幅度取决于使用麻疹疫苗还是麻疹-风疹疫苗以及核查记录人员的技能要求。

要点

  • 选择性接种通过核查接种记录避免已免疫儿童重复接种,可减少疫苗和供应成本。
  • 净成本节约取决于儿童有2剂以上接种史且有记录的高联合概率。
  • 节约幅度受疫苗类型(麻疹疫苗或麻疹-风疹疫苗)和核查人员技能要求影响。

核心结论

  • 在儿童同时具有2剂以上既往含麻疹成分疫苗接种史且有可用记录的高联合概率情境下,选择性接种政策可能实现净成本节约。
  • 净成本节约的幅度高度依赖于国家使用麻疹疫苗还是麻疹-风疹疫苗,以及核查既往接种记录人员的技能要求。

研究设计与样本

  • 研究采用蒙特卡洛模拟评估选择性接种政策在何种条件下可产生净成本节约。

主要发现

  • 在儿童同时具有2剂以上既往麻疹疫苗接种史且有可用记录的高联合概率情境下,可观察到成本节约。
  • 净成本节约的幅度受疫苗类型(麻疹疫苗或麻疹-风疹疫苗)和核查记录人员技能要求的显著影响。

临床怎么用

  • 在补充免疫活动中,可考虑对能提供既往接种记录且已有2剂及以上含麻疹成分疫苗接种史的儿童免于重复接种,以节约疫苗和供应成本。
  • 实施选择性接种需权衡额外工作人员时间和社会动员投入,并考虑疫苗类型和核查人员技能要求对净节约的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Measles vaccination is a cost-effective way to prevent infection and reduce mortality and morbidity. However, in countries with fragile routine immunization infrastructure, coverage rates are still low and supplementary immunization campaigns (SIAs) are used to reach previously unvaccinated children. During campaigns, vaccine is generally administered to every child, regardless of their vaccination status and as a result, there is the possibility that a child that is already immune to measles (i.e. who has had 2+ vaccinations) would receive an unnecessary dose, resulting in excess cost. Selective vaccination has been proposed as one solution to this; children who were able to provide documentation of previous vaccination would not be vaccinated repeatedly. While this would result in reduced vaccine and supply cost, it would also require additional staff time and increased social mobilization investment, potentially outweighing the benefits. We utilize Monte Carlo simulation to assess under what conditions a selective vaccination policy would indeed result in net savings. We demonstrate that cost savings are possible in contexts with a high joint probability of an individual child having both 2+ previous measles doses and also an available record. We also find that the magnitude of net cost savings is highly dependent on whether a country is using measles-only or measles-rubella vaccine and on the required skill set of the individual who would review the previous vaccination records.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hagedorn BL, Dabbagh A, McCarthy KA, et al. The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns. Vaccine. 2019. PMID: 31471145. doi:10.1016/j.vaccine.2019.08.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。